Design and Production of a Clinical Grade Retroviral Vector for a Phase I Clinical Study to Investigate Replacement Gene Therapy for the Treatment of Fanconi Anemia.

1999 | Fred Hutchinson Cancer Research Center | Research Grant

Amount Funded: $61,000

Researchers: Peter Kurre, Hans-Peter Kiem